CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
暂无分享,去创建一个
Michael Y. Gerner | J. Billingsley | M. Pittet | Esther Rheinbay | A. Luster | T. Mempel | R. Sivakumar | F. Marangoni | S. Kobold | F. Zavala | B. Cadilha | Marius Messemaker | Chiara Cianciaruso | S. Lesch | M. D. Pilato | A. Ozga | Daniel W Pérez-Ramos | J. Pruessmann | Esteban Carrizosa | Ross D. Warner | Raphael Kfuri-Rubens | C. Cianciaruso | Esther Rheinbay | Daniel W. Pérez-Ramos
[1] Allon M. Klein,et al. Tumor-infiltrating dendritic cell states are conserved across solid human cancers , 2020, The Journal of experimental medicine.
[2] D. Lambrechts,et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling , 2020, Cell Research.
[3] Deepali V. Sawant,et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer , 2020, Cell.
[4] E. Kenigsberg,et al. A conserved dendritic-cell regulatory program limits antitumour immunity , 2020, Nature.
[5] J. Pober,et al. Complement activated interferon-γ-primed human endothelium transpresents interleukin-15 to CD8+ T cells. , 2020, The Journal of clinical investigation.
[6] T. Waldmann,et al. Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer , 2019, The Journal of experimental medicine.
[7] David M. Schauder,et al. CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer. , 2019, Immunity.
[8] G. Freeman,et al. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. , 2019, Immunity.
[9] Xianwen Ren,et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.
[10] M. Kubo,et al. Interstitial-resident memory CD8+ T cells sustain frontline epithelial memory in the lung , 2019, The Journal of experimental medicine.
[11] Kouji Matsushima,et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways , 2019, The Journal of experimental medicine.
[12] I. Melero,et al. Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.
[13] G. Freeman,et al. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. , 2019, Immunity.
[14] A. Villani,et al. Targeting the CBM complex causes Treg cells to prime tumors for immune checkpoint therapy , 2019, Nature.
[15] Virginia Savova,et al. Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. , 2019, Immunity.
[16] Chun Jimmie Ye,et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity , 2019, Cell.
[17] R. Satija,et al. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.
[18] F. Hodi,et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.
[19] Clark C. Chen,et al. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy , 2019, Nature Communications.
[20] I. Amit,et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma , 2019, Cell.
[21] Daniel E. Speiser,et al. Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.
[22] T. Schumacher,et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers , 2018, Nature Medicine.
[23] Ralph Weissleder,et al. Successful Anti‐PD‐1 Cancer Immunotherapy Requires T Cell‐Dendritic Cell Crosstalk Involving the Cytokines IFN‐&ggr; and IL‐12 , 2018, Immunity.
[24] Paul J. Hoover,et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.
[25] Russell J. Dickson,et al. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory‐like Cells for Sustained Immunity , 2018, Immunity.
[26] M. Fehlings,et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.
[27] Adrian V. Lee,et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.
[28] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[29] E. Sahai,et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control , 2018, Cell.
[30] W. Held,et al. Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation. , 2018, Cell reports.
[31] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[32] A. Kamphorst,et al. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions. , 2018, Annual review of medicine.
[33] Omar K. Yaghi,et al. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils , 2017, Science.
[34] Scott N. Mueller,et al. Chemokine Receptor–Dependent Control of Skin Tissue–Resident Memory T Cell Formation , 2017, The Journal of Immunology.
[35] Christina S. Leslie,et al. Chromatin states define tumor-specific T cell dysfunction and reprogramming , 2017, Nature.
[36] X. Deupí,et al. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion , 2017, PloS one.
[37] A. Elkahloun,et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness , 2016, Science Immunology.
[38] Allon M. Klein,et al. Single-cell barcoding and sequencing using droplet microfluidics , 2016, Nature Protocols.
[39] Sandra P. Calderon-Copete,et al. T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. , 2016, Immunity.
[40] T. Kaisho,et al. Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. , 2016, Cancer cell.
[41] Matheus C. Bürger,et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy , 2016, Nature.
[42] Ting Ni,et al. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection , 2016, Nature.
[43] Xiaodi Wu,et al. Transcriptional Control of Dendritic Cell Development. , 2016, Annual review of immunology.
[44] W. Shi,et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes , 2016, Science.
[45] Rob J de Boer,et al. Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization , 2015, The Journal of Immunology.
[46] K. Odunsi,et al. Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints , 2015, Nature Communications.
[47] Steven J. M. Jones,et al. Genomic Classification of Cutaneous Melanoma , 2015, Cell.
[48] Allon M. Klein,et al. Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells , 2015, Cell.
[49] Sebastian Amigorena,et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. , 2014, Cancer cell.
[50] Andrea J. Radtke,et al. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8⁺ T cells specific for infectious pathogens. , 2014, The Journal of infectious diseases.
[51] D. Speiser,et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? , 2014, Nature Reviews Immunology.
[52] J. Wolchok,et al. Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy , 2014, Journal of Immunotherapy for Cancer.
[53] Ronald N Germain,et al. Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. , 2014, Immunity.
[54] Edward Y Kim,et al. The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. , 2013, Immunity.
[55] E. Yang,et al. Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation , 2013, Nature Immunology.
[56] U. V. von Andrian,et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. , 2012, Immunity.
[57] Susan M. Kaech,et al. Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.
[58] Michael Y. Gerner,et al. Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. , 2012, Immunity.
[59] M. Nussenzweig,et al. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage , 2012, The Journal of experimental medicine.
[60] R. Siebert,et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.
[61] T. Ottenhoff,et al. CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis , 2011, Infection and Immunity.
[62] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[63] A. Telenti,et al. Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses , 2010, Nature Immunology.
[64] G. Freeman,et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection , 2010, Proceedings of the National Academy of Sciences.
[65] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[66] Eliseo F. Castillo,et al. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. , 2008, Blood.
[67] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[68] E. Butcher,et al. Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells1 , 2008, Journal of Immunology.
[69] A. Strasser,et al. Interleukin 15–mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1 , 2007, Nature Immunology.
[70] Felix Scholz,et al. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. , 2007, The Journal of investigative dermatology.
[71] R. Locksley,et al. Visualization of IL-12/23p40 In Vivo Reveals Immunostimulatory Dendritic Cell Migrants that Promote Th1 Differentiation1 , 2006, The Journal of Immunology.
[72] V. Levitsky,et al. Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes , 2005, European journal of immunology.
[73] Mitchell Kronenberg,et al. Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids , 2005, PLoS biology.
[74] B. Chandrasekar,et al. CXCL16 Signals via Gi, Phosphatidylinositol 3-Kinase, Akt, IκB Kinase, and Nuclear Factor-κB and Induces Cell-Cell Adhesion and Aortic Smooth Muscle Cell Proliferation* , 2004, Journal of Biological Chemistry.
[75] E. Butcher,et al. Dendritic Cells Support Sequential Reprogramming of Chemoattractant Receptor Profiles During Naive to Effector T Cell Differentiation 1 , 2003, The Journal of Immunology.
[76] T. Waldmann,et al. IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .
[77] Sharon Engel,et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.
[78] E. Butcher,et al. The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.
[79] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[80] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[81] T. Dassopoulos,et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.
[82] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[83] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[84] N. Breslow,et al. Analysis of Survival Data under the Proportional Hazards Model , 1975 .
[85] Sebastian Amigorena,et al. Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity. , 2014, Cancer cell.
[86] J. Long,et al. Genetic and spectrally distinct in vivo imaging: embryonic stem cells and mice with widespread expression of a monomeric red fluorescent protein , 2005, BMC biotechnology.